International Journal of Gynecological Cancer Q1 Unclaimed
International Journal of Gynecological Cancer, the official journal of ESGO, is the primary educational and informational publication for topics relevant to detection, prevention, diagnosis, and treatment of gynecologic malignancies. The journal is published nine times a year and offers great value to the medical field and to gynecologic oncologists around the world. It provides the latest research in the area of women’s cancer and offers a number of opportunities to learn not only the latest r It has an SJR impact factor of 1,107.
International Journal of Gynecological Cancer focuses its scope in these topics and keywords: cancer, cervical, endometrial, patients, radiation, women, advanced, ovarian, sexual, primary, ...
Type: Journal
Type of Copyright: CC BY
Languages: English
Open Access Policy: Open Choice
Type of publications:
Publication frecuency: 9
2800 €
Inmediate OANPD
Embargoed OA0 €
Non OAMetrics
1,107
SJR Impact factor101
H Index384
Total Docs (Last Year)1036
Total Docs (3 years)9286
Total Refs2825
Total Cites (3 years)782
Citable Docs (3 years)2.58
Cites/Doc (2 years)24.18
Ref/DocOther journals with similar parameters
Human Reproduction Update Q1
American Journal of Obstetrics and Gynecology Q1
Ultrasound in Obstetrics and Gynecology Q1
Obstetrics and Gynecology Q1
Fertility and Sterility Q1
Compare this journals
Aims and Scope
Best articles by citations
Interval cervical cancer following treatment for cervical intraepithelial neoplasia
View moreParametrial involvement as a risk factor
View morep53 Polymorphism (codon-72) has no correlation with the development and the clinical features of cervical cancer
View moreParametrial spread in patients with endometrial carcinoma undergoing radical hysterectomy
View moreGastrointestinal stromal tumor arising in the rectovaginal septum
View moreAggressive endometriosis: report of a case
View moreAre Muslim women less susceptible to oncogenic human papillomavirus infection? A study from rural eastern India
View moreTopotecan in heavily pretreated patients with recurrent ovarian, peritoneal, and fallopian tube carcinoma
View moreVenous Thromboembolism in Advanced Ovarian Cancer Patients Undergoing Frontline Adjuvant Chemotherapy
View morePrognostic factors in young women with endometrial carcinoma: a report of 20 cases and review of literature
View moreCyfra 21-1 marker in carcinoma of the cervix
View moreMalignancies Diagnosed During Pregnancy and Treated With Chemotherapy or Other Modalities (Review of 27 Cases): Multicenter Experiences
View moreAnti-cancer effect of adenovirus p53 on human cervical cancer cell growth in vitro and in vivo
View moreRestoration of tumor specific human leukocyte antigens class I-restricted cytotoxicity by dendritic cell stimulation of tumor infiltrating lymphocytes in patients with advanced ovarian cancer
View moreA case of peripheral primitive neuroectodermal tumor of the ovary
View morePrimary peritoneal serous papillary carcinoma: A new epidemiologic trend? A matched-case comparison with ovarian serous papillary cancer
View moreThe growth factor receptors HER-2/neu and EGFR, their relationship, and their effects on the prognosis in early stage (FIGO I-II) epithelial ovarian carcinoma
View moreBrain metastases from epithelial ovarian carcinoma
View moreA retrospective comparison of current and proposed staging and scoring systems for persistent gestational trophoblastic disease
View moreMultiple, disseminated cutaneous metastases of vulvar squamous cell carcinoma
View morePostoperative concurrent chronomodulated 5-fluorouracil/leucovorin infusion and pelvic radiotherapy for squamous cell carcinoma of the ovary arising from mature cystic teratoma
View moreA pharmacokinetic and clinical evaluation of thio-TEPA in combination with cisplatin as first-line chemotherapy for advanced epithelial ovarian carcinoma
View moreLetters to the Editor
View moreA comparison of prognoses of FIGO stage IB adenocarcinoma and squamous cell carcinoma
View more
Comments